2.67 USD
↘ 0.11 (3.96%)AT CLOSE (03:59 PM EDT)
Zentalis Pharmaceuticals, Inc. Common Stock
ZNTLNASDAQ • USD
2.70
↗ 0.03 (1.12%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
2.70
↗ 0.03 (1.12%)
Market: CLOSED
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is currently trading at $2.66. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 6, 2026.
Open?$2.81
High?$2.82
Low?$2.65
Prev. Close?$2.78
Volume?827.9K
Avg. Volume?1.2M
VWAP?$2.72
Rel. Volume?0.70x
Bid / Ask
Bid?$2.64 × 100
Ask?$2.71 × 100
Spread?$0.07
Midpoint?$2.68
Valuation & Ratios
Market Cap?263.2M
Shares Out?71.7M
Float?66.0M
Float %?69.7%
P/E Ratio?N/A
P/B Ratio?1.83
EPS?-$1.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
263.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
SAN DIEGO, CA 92121
Phone: (858) 263-4333
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?60
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.60Distress
Confidence?56%Low
Short InterestHigh
Short % of Float?7.25%Elevated
Short Interest?4.8M
Days to Cover?5.2
Free Float66.0M
Avg Daily Volume913.6K
Settlement Date2026-09-15
Financial Health
Current Ratio?4.82Strong
Quick Ratio?4.82Strong
Cash Ratio?0.66Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.83CHEAP▾
Peers100
S&P79
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-97.2%WEAK▾
S&P3
ROA?-64.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-128129000
Enterprise Value?$238.4M
Fundamentals ratios updated end of day